3.2.8 Gamma-secretase inhibitors Interesting evidence indicates that sub-chronic treatment (twice-a-day for 12 days) and acute administration of semagacestat (LY-450139), a gamma-secretase inhibitor, at a dose that reduces Aβ levels produces a reduction in power of hippocampal θ activity elici...